Site icon Rare Disease Innovations Institute

Well-intended measure will throttle pharma innovation

More than one million North Carolinian patients are affected by a rare disease. Tara Britt, our founder, argues that removing IP protections from medical innovation will lead to less cures and treatments for rare diseases. Keep reading in @dailyreflector:

Exit mobile version